nach oben

Erschienen in:

10.01.2022 | COVID-19 | Original article Zur Zeit gratis

Analysis of neurology consultations in hospitalized patients with COVID-19

verfasst von: Merve Hazal Ser, Uygur Tanrıverdi, Çiğdem Özkara, Sabahattin Saip, Ceren Aliş, Zeynep Ece Kaya Güleç, Gözde Nezir, Esra Koçhan Kızılkılıç, Merve Aktan Süzgün, Hikmet Abbaszade, Şermin Börekçi, Rıdvan Karaali, Osman Kızılkılıç, Ayşegül Gündüz, Feray Karaali Savrun

Erschienen in: Acta Neurologica Belgica | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to evaluate patients who were hospitalized with a diagnosis of COVID-19 and were consulted by neurology during their hospital stay.

Methods

All files of patients with COVID-19 who were admitted to Cerrahpasa Medical Faculty Hospital between March 11th and December 31st, 2020 were retrospectively reviewed, and files of patients who consulted by neurology during their stay were included. Demographic and clinical characteristics, neurologic diagnosis, outcome and related laboratory data were extracted from electronic medical records and analyzed. Patients were categorized into the first wave and second wave according to the date of hospitalization.

Results

A total of 2257 patients were hospitalized for COVID-19; among them, 127 were consulted by a neurologist during their hospital stay. Fifteen patients received a consultation for possible drug interactions. Among the remaining 112 patients, the reason for neurology consultation was i. exacerbation of a neurological comorbidity vs ii. new-onset neurological manifestations. The median age was 68.5 ± 14.2 years, and 60.7% were men. Dementia and stroke were the leading neurological comorbidities. COVID-19 disease was more severe in the patients with the new-onset neurological comorbidity than in patients with exacerbation of a neurological comorbidity (p = 0.07). Serum creatinine kinase levels were higher in the new-onset patient group (p < 0.05). Exacerbation of previous neurological disease or new neurological impairment were jointly and severely related to high mortality (overall 35/112 vs 275/2145, p < 0.001; exacerbation 12/45 vs 275/2145 p < 0.01; new-onset 23/67 vs 275/2145, p < 0.001).

Conclusion

Serious neurological involvement is relatively uncommon in hospitalized patients with COVID-19 and is associated with increased mortality.

Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/NEJMoa2001017CrossRefPubMedPubMedCentral

WHO Director-General’s opening remarks at the media briefing on COVID-19 - 25 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---25-march-2020. Accessed 17 Apr 2021

Genel Koronavirüs Tablosu. https://covid19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html. Accessed 17 Apr 2021

Jin Y, Yang H, Ji W et al (2020) Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 12:372. https://doi.org/10.3390/v12040372CrossRefPubMedCentral

Rhea EM, Logsdon AF, Hansen KM et al (2021) The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nat Neurosci 24:368–378. https://doi.org/10.1038/s41593-020-00771-8CrossRefPubMed

Gu J, Gong E, Zhang B et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202:415–424. https://doi.org/10.1084/jem.20050828CrossRefPubMedPubMedCentral

Zubair AS, McAlpine LS, Gardin T et al (2020) Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol 77:1018–1027. https://doi.org/10.1001/jamaneurol.2020.2065CrossRefPubMedPubMedCentral

Bolay H, Gül A, Baykan B (2020) COVID-19 is a Real Headache! Headache 60:1415–1421. https://doi.org/10.1111/head.13856CrossRefPubMedPubMedCentral

Saniasiaya J, Kulasegarah J (2021) Dizziness and COVID-19. Ear Nose Throat J 100:29–30. https://doi.org/10.1177/0145561320959573CrossRefPubMed

10.

Avula A, Nalleballe K, Narula N et al (2020) COVID-19 presenting as stroke. Brain Behav Immun 87:115–119. https://doi.org/10.1016/j.bbi.2020.04.077CrossRefPubMedPubMedCentral

11.

Bagnato S, Boccagni C, Marino G et al (2020) Critical illness myopathy after COVID-19. Int J Infect Dis 99:276–278. https://doi.org/10.1016/j.ijid.2020.07.072CrossRefPubMedPubMedCentral

12.

Iaconetta G, De Luca P, Scarpa A et al (2020) Meningoencephalitis Associated with SARS-Coronavirus-2. Transl Med UniSa 23:42–47CrossRef

13.

Toscano G, Palmerini F, Ravaglia S et al (2020) Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med 382:2574–2576. https://doi.org/10.1056/NEJMc2009191CrossRefPubMed

14.

Sousa GJB, Garces TS, Cestari VRF et al (2020) Mortality and survival of COVID-19. Epidemiol Infect. https://doi.org/10.1017/S0950268820001405CrossRefPubMed

15.

Bianchetti A, Rozzini R, Guerini F et al (2020) Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging 24:560–562. https://doi.org/10.1007/s12603-020-1389-1CrossRefPubMedPubMedCentral

16.

Cilia R, Bonvegna S, Straccia G et al (2020) Effects of COVID-19 on parkinson’s disease clinical features: a community-based case-control study. Mov Disord 35:1287–1292. https://doi.org/10.1002/mds.28170CrossRefPubMedPubMedCentral

17.

Fasano A, Antonini A, Katzenschlager R et al (2020) Management of advanced therapies in parkinson’s disease patients in times of humanitarian crisis: The COVID-19 experience. Mov Disord Clin Pract 7:361–372. https://doi.org/10.1002/mdc3.12965CrossRefPubMedPubMedCentral

18.

Guidon AC, Amato AA (2020) COVID-19 and neuromuscular disorders. Neurology 94:959–969. https://doi.org/10.1212/WNL.0000000000009566CrossRefPubMed

19.

Parrotta E, Kister I, Charvet L et al (2020) COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center. Neurology - Neuroimmunology Neuroinflammation. https://doi.org/10.1212/NXI.0000000000000835CrossRef

20.

Organization WH (2020) Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization

21.

Cagnazzo F, Arquizan C, Derraz I et al (2021) Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J Neurol 268:2656–2665. https://doi.org/10.1007/s00415-020-10285-9CrossRefPubMed

22.

Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032CrossRefPubMed

23.

Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:683–690. https://doi.org/10.1001/jamaneurol.2020.1127CrossRefPubMed

24.

Sharifian-Dorche M, Huot P, Osherov M et al (2020) Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 417:117085. https://doi.org/10.1016/j.jns.2020.117085CrossRefPubMedPubMedCentral

25.

Yuksel H, Gursoy GT, Dirik EB et al (2021) Neurological manifestations of COVID-19 in confirmed and probable cases: A descriptive study from a large tertiary care center. J Clin Neurosci 86:97–102. https://doi.org/10.1016/j.jocn.2021.01.002CrossRefPubMedPubMedCentral

26.

Amanat M, Rezaei N, Roozbeh M et al (2021) Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurol 21:116. https://doi.org/10.1186/s12883-021-02152-5CrossRefPubMedPubMedCentral

27.

Herman C, Mayer K, Sarwal A (2020) Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology 95:77–84. https://doi.org/10.1212/WNL.0000000000009673CrossRefPubMed

28.

Xu S, Li Y (2020) Beware of the second wave of COVID-19. Lancet 395:1321–1322. https://doi.org/10.1016/S0140-6736(20)30845-XCrossRefPubMedPubMedCentral

29.

García-Azorín D, Martínez-Pías E, Trigo J et al (2020) Neurological comorbidity is a predictor of death in Covid-19 disease: A Cohort Study on 576 patients. Front Neurol 11:781–781. https://doi.org/10.3389/fneur.2020.00781CrossRefPubMedPubMedCentral

30.

Danoun OA, Zillgitt A, Hill C et al (2021) Outcomes of seizures, status epilepticus, and EEG findings in critically ill patient with COVID-19. Epilepsy Behav 118:107923. https://doi.org/10.1016/j.yebeh.2021.107923CrossRefPubMedPubMedCentral

31.

Zeng C, Meng H, Zhu Y et al (2021) Correlation of seizure increase and COVID-19 outbreak in adult patients with epilepsy: findings and suggestions from a nationwide multi-centre survey in China. Seizure 88:102–108. https://doi.org/10.1016/j.seizure.2021.03.029CrossRefPubMedPubMedCentral

32.

Helms J, Kremer S, Merdji H et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382:2268–2270. https://doi.org/10.1056/NEJMc2008597CrossRefPubMed

33.

Cipriani G, Danti S, Nuti A et al (2020) A complication of coronavirus disease 2019: delirium. Acta Neurol Belg 120:927–932. https://doi.org/10.1007/s13760-020-01401-7CrossRefPubMedPubMedCentral

34.

Atiyat R, Veeraballi S, Al-Atiyat N et al (2021) A rare case report of persistent hiccups as an atypical presentation of COVID-19. Cureus 13:e13625. https://doi.org/10.7759/cureus.13625CrossRefPubMedPubMedCentral

35.

Ikitimur H, Borku Uysal B, Ikitimur B et al (2021) Case report: two cases of persistent hiccups complicating COVID-19. Am J Trop Med Hyg. https://doi.org/10.4269/ajtmh.21-0190CrossRefPubMedPubMedCentral

36.

Totomoch-Serra A, Ibarra-Miramon CB, Manterola C (2021) Persistent hiccups as main COVID-19 symptom. Am J Med Sci. https://doi.org/10.1016/j.amjms.2021.01.001CrossRefPubMedPubMedCentral

Titel: Analysis of neurology consultations in hospitalized patients with COVID-19
verfasst von: Merve Hazal Ser
Uygur Tanrıverdi
Çiğdem Özkara
Sabahattin Saip
Ceren Aliş
Zeynep Ece Kaya Güleç
Gözde Nezir
Esra Koçhan Kızılkılıç
Merve Aktan Süzgün
Hikmet Abbaszade
Şermin Börekçi
Rıdvan Karaali
Osman Kızılkılıç
Ayşegül Gündüz
Feray Karaali Savrun
Publikationsdatum: 10.01.2022
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Acta Neurologica Belgica / Ausgabe 4/2022
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-021-01836-6

Autonomic dysfunction in patients with COVID‑19

COVID-19
Original article

Frequency of diencephalic syndrome in NMOSD

Original article

Congenital absence of the unilateral internal carotid artery. Report of two cases with radiological images

Neuro-Images

Post-alemtuzumab Graves’ disease remitting after switch to ocrelizumab

Letter to the Editor

Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications

COVID-19
Review article

Isolated mitochondrial myopathy due to m.3243A > G mutation in MT-TL1 gene

Letter to the Editor

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

12.01.2025
Computertomografie
Nachrichten

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

CGRP-Antikörper auch bei älteren Migränekranken sicher

09.01.2025
Migräne
Nachrichten

Beginnen ältere Migränekranke eine Prophylaxe mit CGRP-Antikörpern, kommt es anschließend nicht häufiger zu kardiovaskulären Problemen als unter einer Prophylaxe mit Botulinumtoxin. Darauf deutet eine US-Analyse von Medicare-Versicherten.

Frühwarnzeichen für multiple Sklerose bei Kindern und Jugendlichen

09.01.2025
Multiple Sklerose
Nachrichten

Ein Forschungsteam aus Deutschland und Kanada hat eine Reihe metabolischer, okulärer, muskuloskelettaler, gastrointestinaler und kardiovaskulärer Symptome identifiziert, die bei Kindern und Jugendlichen der Diagnose einer multiplen Sklerose (MS) vorausgehen können.

Migräne verstehen und psychotherapeutisch behandeln

31.12.2024
Migräne
Podcast

Das Wissen über die Mechanismen, die im Gehirn bei einer Migräneattacke ablaufen, und mögliche Auslöser wird immer breiter. Der psychologische Psychotherapeut Dr. Dipl.-Psych. Timo Klan fasst den aktuellen Erkenntnisstand zusammen. Und er gibt Tipps für eine differenzierte, individuelle Diagnostik auch von Begleiterkrankungen und beschreibt erfolgreiche psychotherapeutische Interventionen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Die Leitlinien für Ärztinnen und Ärzte, Arzt und Ärztin unkenntlich diskutieren Gehirn-Scans/© gorodenkoff / Getty Images / iStock (Symbolbild mit Fotomodellen), Senior mit Kopfschmerz/© Motortion / Getty Images / iStock (Symbolbild mit Fotomodell), Kind wird von einer Ärztin befragt/© Monkey Business / Stock.adobe.com (Symbolbild mit Fotomodellen), Springer Medizin Podcast - Migräne/© (M) Foto: goodluz / stock.adobe.com (Symbolbild mit Fotomodell)